U.S. Food and Drug Administration Commissioner Scott Gottlieb says a new guidance will provide manufacturers and payers a safe harbor to discuss off-label drug uses, the Pink Sheet reports.
Gottlieb says the guidance will be issued “very soon.”
To read the full report on the Pink Sheet, click here.
